ArticleProceedings of the National Academy of Sciences of the United States of America2012

Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases.

David P Kodack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.